Orion Development Corp.

GTx Offers Strong Phase IIb With Prostate Cancer Stopper.
BIOWORLD Today; 11/3/2009; 1305 words; ...citrate worldwide for prostate cancer from Finland-based Orion Corp. The estrogen-blocking drug already is approved for...adding that the company will have more news about their development in the first quarter. (javascript:RightslinkPopUp...

Nutra Pharma Raising $9.6M For ReceptoPharm Subsidiary.
BIOWORLD Today; 11/3/2009; 1450 words; ...Writer Nutra Pharma Corp. entered a $9.6...to pay research and development costs for the two lead...purposes, including the development of the company's portfolio...underwriters led by Orion Securities Inc., of...proceeds for research and development, clinical trials...

Other News To Note.
BIOWORLD Today; 11/3/2009; 2358 words; ...o Altea Therapeutics Corp., of Atlanta, completed...capital. o AmpliMed Corp., of Tucson, Ariz...for use in research and development of HDL therapies with...underwriters is being led by Orion Securities Inc., of...research. o Invitrogen Corp., of Carlsbad, Calif...

Appointments And Advancements.
BIOWORLD Today; 11/3/2009; 1079 words; ...president of product development and manufacturing. Harvard...Genomic Solutions. ICOS Corp., of Bothell, Wash...president of pharmaceutical development and manufacturing operations...Lievonen to its board. Orion Genomics LLC, of St...to its board. Pharmos Corp., of Iselin, N.J...

Pharmasset Files For $75M IPO; Caprion Bids To Go Public, Too.
BIOWORLD Today; 11/3/2009; 899 words; ...used for "clinical development programs, primarily...Racivir, for research and development related to our preclinical...Shiga toxin Stx2, in development by Teijin Pharma Ltd...GMP Securities LP and Orion Securities Inc., both...includes Canaccord Capital Corp., of Vancouver, British...